Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DTx Pharma

DTx Pharma
2017 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of a technology intended to facilitate the delivery of double-stranded oligonucleotide therapeutics to multiple cell types and tissues. The company is currently operating in Stealth mode.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 13284 Gunner Avenue
  • San Diego, CA 92129
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore DTx Pharma’s full profile, request a free trial.

DTx Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Aug-2017 Completed Stealth
To view this company’s complete deal history including valuation and funding, request access »

DTx Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0

DTx Pharma Executive Team (2)

Name Title Board
Seat
Contact
Info
Arthur Suckow Ph.D President & Chief Executive Officer
Adam Pavlicek Ph.D Co-Founder